Source: BrainStorm Cell Therapeutics via Stem Cell Business News
Posted: Monday, July 24, 2006
Tel Aviv, Israel-based BrainStorm Cell Therapeutics (BCLI) said on July 11 it has advanced its patent application from a provisional to an international patent application for a new procedure to derive “neuronal-supporting cells” from adult bone marrow with the U.S. Patent and Trademark Office.
The patent protects a procedure for inducing bone marrow stem cells to differentiate into astrocytes, which are brain cells that naturally support neurons in the brain.
No comments:
Post a Comment